| Pharmaceutical active ingredients: |
| Nonoxynol 9 |
| Available forms, composition and doses of Liponox NCY: |
| N / A |
| Liponox NCY medical category: |
| Human:ContraceptivesSpermicidal agentsSurfactants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G02BB - Intravaginal contraceptives |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lipo-Diazine | Sulfadiazine | Unidentified Pharmaceutical Company |
| Lipo-Levazine | Sulfadiazine | Unidentified Pharmaceutical Company |
| Lipolutin | Progesterone | Unidentified Pharmaceutical Company |
| Lipo-Lutin | Progesterone | Unidentified Pharmaceutical Company |
| Lipomid | Clofibrate | Unidentified Pharmaceutical Company |
| Lipopac | Paclitaxel | Unidentified Pharmaceutical Company |
| Liporeduct | Clofibrate | Unidentified Pharmaceutical Company |
| Liporil | Clofibrate | Unidentified Pharmaceutical Company |
| Liposid | Clofibrate | Unidentified Pharmaceutical Company |
| Liposorb | Polysorbate 20 | Unidentified Pharmaceutical Company |